X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (244) 244
male (162) 162
female (129) 129
middle aged (129) 129
jejunal neoplasms - drug therapy (109) 109
aged (100) 100
jejunal neoplasms - pathology (89) 89
adult (86) 86
jejunal neoplasms - surgery (83) 83
index medicus (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (62) 62
surgery (52) 52
jejunal neoplasms - diagnosis (51) 51
oncology (49) 49
gastroenterology & hepatology (45) 45
treatment outcome (44) 44
jejunal neoplasms - complications (39) 39
cancer (38) 38
tomography, x-ray computed (36) 36
combined modality therapy (34) 34
antineoplastic agents - therapeutic use (33) 33
chemotherapy (33) 33
adenocarcinoma - drug therapy (32) 32
retrospective studies (31) 31
liver neoplasms - secondary (29) 29
chemotherapy, adjuvant (28) 28
medicine & public health (28) 28
gastrointestinal stromal tumors - drug therapy (27) 27
imatinib mesylate (27) 27
ileal neoplasms - pathology (26) 26
aged, 80 and over (25) 25
ileal neoplasms - drug therapy (25) 25
jejunal neoplasms - diagnostic imaging (25) 25
tumors (25) 25
adenocarcinoma - surgery (24) 24
gastrointestinal stromal tumors - surgery (24) 24
follow-up studies (23) 23
prognosis (22) 22
diagnosis, differential (20) 20
duodenal neoplasms - pathology (20) 20
fatal outcome (20) 20
gastroenterology (20) 20
gastrointestinal hemorrhage - etiology (20) 20
neoplasm staging (20) 20
ileal neoplasms - surgery (19) 19
jejunal neoplasms - secondary (19) 19
piperazines - therapeutic use (19) 19
pyrimidines - therapeutic use (19) 19
stomach neoplasms - surgery (19) 19
adenocarcinoma - pathology (18) 18
benzamides (18) 18
diagnosis (18) 18
jejunal diseases - etiology (18) 18
prognostic-factors (18) 18
medicine, general & internal (17) 17
adenocarcinoma (16) 16
adolescent (16) 16
duodenal neoplasms - drug therapy (16) 16
peritoneal neoplasms - secondary (16) 16
jejunal neoplasms - therapy (15) 15
liver neoplasms - drug therapy (15) 15
gastrointestinal stromal tumors - pathology (14) 14
peritoneal neoplasms - drug therapy (14) 14
risk factors (14) 14
small intestine (14) 14
duodenal neoplasms - surgery (13) 13
gastrointestinal stromal tumors - complications (13) 13
intestinal obstruction - etiology (13) 13
jejunal neoplasms - mortality (13) 13
management (13) 13
survival analysis (13) 13
time factors (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
capsule endoscopy (12) 12
carcinoma (12) 12
cisplatin - administration & dosage (12) 12
gastrointestinal stromal tumors - diagnosis (12) 12
recurrence (12) 12
small-intestine (12) 12
surgical oncology (12) 12
adenocarcinoma - therapy (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
biopsy (11) 11
carcinoid tumor - drug therapy (11) 11
fluorouracil - therapeutic use (11) 11
jejunal diseases - diagnostic imaging (11) 11
jejunum - surgery (11) 11
metastasis (11) 11
remission induction (11) 11
abdominal pain - etiology (10) 10
case report (10) 10
gastrointestinal stromal tumors - diagnostic imaging (10) 10
ileal neoplasms - mortality (10) 10
intestinal neoplasms - drug therapy (10) 10
jejunal neoplasms - genetics (10) 10
radiotherapy (10) 10
survival (10) 10
adenocarcinoma - diagnosis (9) 9
adenocarcinoma - secondary (9) 9
animals (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (190) 190
Japanese (37) 37
German (8) 8
Spanish (6) 6
French (5) 5
Hungarian (4) 4
Italian (4) 4
Korean (2) 2
Danish (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 03/2010, Volume 21, Issue 9, pp. 1786 - 1793
Journal Article
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 06/2012, Volume 23, Issue 5, pp. 561 - 566
This study aimed at assessing the efficacy and safety of biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified... 
5-fluorouracil | oxaliplatin | advanced small bowel adenocarcinoma | leucovorin | chemotherapy | UNITED-STATES | PROGNOSTIC-FACTORS | FLUOROURACIL | ADVANCED COLORECTAL-CANCER | TRIAL | CAPECITABINE | ONCOLOGY | ADVANCED GASTRIC-CANCER | PHARMACOLOGY & PHARMACY | EXPERIENCE | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Duodenal Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Jejunal Neoplasms - mortality | Fluorouracil - therapeutic use | Jejunal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Duodenal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Duodenal Neoplasms - pathology | Ileal Neoplasms - pathology | Ileal Neoplasms - mortality | Kaplan-Meier Estimate | Adenocarcinoma - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Ileal Neoplasms - drug therapy | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - mortality | Jejunal Neoplasms - pathology | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 18, pp. 3494 - 3501
BACKGROUND Oxaliplatin in combination with either 5‐fluorouracil or capecitabine is commonly used as first‐line therapy for patients with small bowel... 
jejunal | duodenal | UDP glucuronosyltransferase family 1 member A1 (UGT1A1) | ileal | small bowel adenocarcinoma | 1A1 | LEUCOVORIN | INSTABILITY | PROXIMAL COLON | FOLFIRI PLUS BEVACIZUMAB | FLUOROURACIL | METASTATIC COLORECTAL-CANCER | GENE | ONCOLOGY | FOLFOXIRI | UGT1A1 GENOTYPE | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Intestine, Small - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Dose-Response Relationship, Drug | Glucuronosyltransferase - genetics | Neoplasm Invasiveness - pathology | Adult | Female | Retrospective Studies | Camptothecin - analogs & derivatives | Databases, Factual | Camptothecin - adverse effects | Pharmacogenetics | Intestinal Neoplasms - mortality | Camptothecin - therapeutic use | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Genotype | Capecitabine - therapeutic use | Cancer Care Facilities | Adenocarcinoma - drug therapy | Intestinal Neoplasms - pathology | Disease-Free Survival | Maximum Tolerated Dose | Capecitabine - adverse effects | Intestine, Small - drug effects | Survival Analysis | Aged | Neoplasm Staging | Intestinal Neoplasms - drug therapy | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - mortality | Small intestine cancer | Cancer patients | Care and treatment | Drug therapy | Adenocarcinoma | Therapy | 5-Fluorouracil | Toxicity | Cancer therapies | Anticancer properties | Confidence intervals | Genotype & phenotype | Oxaliplatin | Jejunum | Intestine | Genotypes | Glucuronosyltransferase | Dosing | Duodenum | Feasibility studies | Pharmacology | Group dynamics | Patients | Survival | Ileum | Irinotecan | Response rates | Antitumor activity | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Neurologia medico-chirurgica, ISSN 0470-8105, 2014, Volume 54, Issue 8, pp. 664 - 669
Gastrointestinal stromal tumors (GISTs) are rare malignant tumors and only a few reported cases of brain metastases can be found. Introduction of a new... 
sunitinib | gastrointestinal stromal tumor | brain metastasis | Sunitinib | Brain metastasis | Gastrointestinal stromal tumor
Journal Article
The Laryngoscope, ISSN 0023-852X, 06/2010, Volume 120, Issue 6, pp. 1103 - 1108
Journal Article